Avaxia Biologics Inks $2.2M
Lexington, Mass.-based Avaxia Biologics Inc. has closed on $2.2 million in Series A financing. Cherrystone Angels of Providence, Rhode Island, led the round, with participation from Boston Harbor Angels and other individual investors. Robert Manning, the co-Chairman of Cherrystone Angels, will join the Avaxia board. Avaxia is developing oral antibody drugs that act locally within the gastrointestinal tract.
10 November 2011•2 mins read
